# FDA Inspection 774405 - Biomat USA, Inc - March 16, 2012

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/02421087-51af-4e8f-a87b-fe84a720ce90
Source feed: FDA_Inspections

> FDA Inspection 774405 for Biomat USA, Inc on March 16, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 774405
- Company Name: Biomat USA, Inc
- Inspection Date: 2012-03-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1169082 - 2022-04-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/16b89fc8-2919-490a-93c1-40942168b26c)
- [FDA Inspection 1169082 - 2022-04-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/2193b328-e6b6-4923-ae37-ad7c604e88c1)
- [FDA Inspection 1000746 - 2017-01-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/2b4634aa-055d-4713-9a8d-ec1dce9f1611)

Company: https://www.keypedia.com/companies/biomat-usa-inc/1919eeef-d5ce-4d17-a2b4-b799fb40ce3a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d